Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-279-1 | CAS number: 118-82-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
In a study on rats, a big proportion of a single oral dose of 14C test substance to rats is eliminated in 24 days: 89.4-97.5% of the label is excreted in the faeces (much of this is eliminated in the first 4 days after dosage), 1% in the urine and < 0.1% in the expired gases. 3.46 and 3.42% of 14C respectively are present in the carcass and viscera of male and female rats after removal of the gut. Rats do not show a sex difference in the pattern of elimination of the test substance and its metabolites.
After ingestion of [14C] test substance the fatty tissues account for the retention of 14C.
Measurement of 14C in the bile of animals with biliary fistulae in conjunction with other data implies that one-fifth of a single dose of [14C] test substance is absorbed. 87% of 14C in the faeces is due to unchanged test substance, 5% to the quinone methide, 5% to the free acid and 3% to an unidentified polar constituent. Three-fifths of 14C in the urine is due to 3,5-di-tert.-butyl-4-hydroxybenzoid acid and the remainder to the ester glucuronide. In several animals, one-half of 14C in the bile is due to the free acid, one quarter to the ester glucuronide and the remainder to unchanged antioxidant, whereas, in others, all of 14C in the bile is due to test substance. 97% of 14C in the body fat is due to unchanged antioxidant and the remainder to the free acid.
Up to 20% of a single oral dose of the test substance is absorbed in rats: 13-14% is metabolized. 3,5-di-tert.-butyl-4-hydroxybenzoic acid accounts for > 5% of a dose of the test substance, 3,5-di-tert.-butyl-4-hydroxybenzoyl-β-Dglucopyranosiduronic acid for < 0.4%, the quinone methide for > 5% and an unidentified compound for < 3%.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
A reliable study in rats (Hathaway and Wright, 1965), a big proportion of a single oral dose of 14C test substance to rats is eliminated in 24 days: 89.4-97.5% of the label is excreted in the faeces (much of this is eliminated in the first 4 days after dosage), 1% in the urine and < 0.1% in the expired gases. 3.46 and 3.42% of 14C respectively are present in the carcass and viscera of male and female rats after removal of the gut. Rats do not show a sex difference in the pattern of elimination of the test substance and its metabolites.
After ingestion of [14C] test substance the fatty tissues account for the retention of 14C.
Measurement of 14C in the bile of animals with biliary fistulae in conjunction with other data implies that one-fifth of a single dose of [14C] test substance is absorbed. 87% of 14C in the faeces is due to unchanged test substance, 5% to the quinone methide, 5% to the free acid and 3% to an unidentified polar constituent. Three-fifths of 14C in the urine is due to 3,5-di-tert.-butyl-4 -hydroxybenzoid acid and the remainder to the ester glucuronide. In several animals, one-half of 14C in the bile is due to the free acid, one-quarter to the ester glucuronide and the remainder to unchanged antioxidant, whereas, in others, all of 14C in the bile is due to test substance. Only a low percentage of the test substance was retained in body fat. 97% of 14C in the body fat is due to unchanged antioxidant and the remainder to the free acid.
Up to 20% of a single oral dose of the test substance is absorbed in rats: 13-14% is metabolized. 3,5-di-tert.-butyl-4 -hydroxybenzoic acid accounts for > 5% of a dose of the test substance, 3,5-di-tert.-butyl-4-hydroxybenzoyl-βDglucopyranosiduronic
acid for < 0.4%, the quinone methide for > 5% and an unidentified compound for < 3%.
In an additional unreliable study on monkeys (Smith, 1970) the levels of14C activity in blood, plasma, urine, faeces and tissues have been determined in two monkeys which were dosed daily in the diet for 31 days with unlabelled substance then on day 32 intubated with approximately 130 mg/kg of a mixture of unlabelled & radiolabelled test material in corn oil. One animal was sacrificed at 24 hours, and the other at 66.5 hours, after treatment.The blood and plasma levels reached a maximum at 8 hours and showed little decline in the next 16 hours. The blood level dropped rapidly in the 24 to 48 hours interval and then fell more slowly towards 66.5 hours.The test material exhibits a low bioaccumulation potential, with the total distribution of 14C material in tissues being 1.56% after 66.5 hours.
Results from old unreliable in vivo pharmacology studies indicate that the substance undergoes much better absorption from non-aqueous media.
It is anticipated that absorption via the oral route is higher than absorption after dermal or inhalation exposure due to the emulsifying function of bile acids and longer contact time and surface area in the GI tract.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2